Establishment of polyclonal human induced pluripotent stem cell lines from peripheral blood using a semi-automated processing system
Regenerative Therapy · 2026-12 · 33 · 101201
DOI: 10.1016/j.reth.2026.101201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Therapy, 2026-12. Verfasst von Yohei Hayashi und 10 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Japan Science and Technology Agency.
Abstract (Originalsprache)
Introduction
The generation of human induced pluripotent stem cells (hiPSCs) with homogeneous and stable quality at an affordable cost is key to industrialize hiPSC-based cell therapies and drug development; however, conventional manual production is labor-intensive and difficult to standardize. Automated closed-system approaches can improve reproducibility, reduce contamination risk, and enable scale-out manufacturing, yet concerns remain regarding the quality of hiPSCs produced using this approach specialized in hiPSC generation from peripheral blood cells.
Methods
Here we developed a prototype semi-automated hiPSC production system to generate polyclonal hiPSC lines from peripheral blood cells. The semi-automated device consists of a spiral microfluidic module for leukocyte separation, followed by modules for leukocyte expansion culture and the transduction of a Sendai virus (SeV) vector carrying reprogramming factors. Subsequently, the transduced leukocytes were manually cultured and expanded to generate polyclonal hiPSC lines.
Results
The generated polyclonal hiPSC populations maintained a normal karyotype and carried minimal residual SeV vector. Importantly, they exhibited self-renewing capacity and pluripotency comparable to those of established clonal hiPSC lines. Furthermore, when subjected to directed differentiation towards cartilage and kidney organoids, the polyclonal hiPSC lines efficiently differentiated into these lineages.
Conclusions
The semi-automated system enabled the generation of high-quality polyclonal hiPSC lines, which will hold promise for future applications in cell therapy and drug development.
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- Japan Science and Technology Agency
Zitieren
APA
Hayashi, Y., Oe, S., Owaki, Y., Miki, T., Kamura, K., Lu, Y., Kano, M., Fujisawa, Y., Takao, T., Taguchi, A., & Takarada, T. (2026). Establishment of polyclonal human induced pluripotent stem cell lines from peripheral blood using a semi-automated processing system. Regenerative Therapy, 33, 101201. https://doi.org/10.1016/j.reth.2026.101201
Vancouver
Hayashi Y, Oe S, Owaki Y, Miki T, Kamura K, Lu Y, et al. Establishment of polyclonal human induced pluripotent stem cell lines from peripheral blood using a semi-automated processing system. Regenerative Therapy. 2026;33:101201. doi:10.1016/j.reth.2026.101201
BibTeX
@article{Hayashi2026,
author = {Hayashi, Yohei and Oe, Suzu and Owaki, Yusuke and Miki, Tsutomu and Kamura, Keiichiro and Lu, Yan and Kano, Momoko and Fujisawa, Yuki and Takao, Tomoka and Taguchi, Atsuhiro and Takarada, Takeshi},
title = {Establishment of polyclonal human induced pluripotent stem cell lines from peripheral blood using a semi-automated processing system},
journal = {Regenerative Therapy},
year = {2026},
volume = {33},
pages = {101201},
doi = {10.1016/j.reth.2026.101201}
}
EUVIMED